Similar articles for PMID: 26577829

Year	Number of Results
1997	1
2003	2
2004	3
2005	1
2006	3
2007	3
2008	1
2009	3
2010	5
2011	9
2012	7
2013	7
2014	12
2015	8
2016	11
2017	4
2019	2
2020	2
2021	1
2022	1
2024	0

1

GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI.

Pu F, Qiao J, Xue S, Yang H, Patel A, Wei L, Hekmatyar K, Salarian M, Grossniklaus HE, Liu ZR, Yang JJ. Pu F, et al. Sci Rep. 2015 Nov 18;5:16214. doi: 10.1038/srep16214. Sci Rep. 2015. PMID: 26577829 Free PMC article.

2

ProCA1.GRPR: a new imaging agent in cancer detection.

Pu F, Xue S, Yang JJ. Pu F, et al. Biomark Med. 2016 May;10(5):449-52. doi: 10.2217/bmm-2016-0040. Epub 2016 Apr 13. Biomark Med. 2016. PMID: 27071673 Free PMC article. No abstract available.

3

Protein-based MRI contrast agents for molecular imaging of prostate cancer.

Wei L, Li S, Yang J, Ye Y, Zou J, Wang L, Long R, Zurkiya O, Zhao T, Johnson J, Qiao J, Zhou W, Castiblanco A, Maor N, Chen Y, Mao H, Hu X, Yang JJ, Liu ZR. Wei L, et al. Mol Imaging Biol. 2011 Jun;13(3):416-423. doi: 10.1007/s11307-010-0342-9. Mol Imaging Biol. 2011. PMID: 20574851 Free PMC article.

4

Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.

Zhang H, Desai P, Koike Y, Houghton J, Carlin S, Tandon N, Touijer K, Weber WA. Zhang H, et al. J Nucl Med. 2017 Jan;58(1):29-35. doi: 10.2967/jnumed.116.176099. Epub 2016 Aug 11. J Nucl Med. 2017. PMID: 27516447 Free PMC article.

5

A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.

Pan D, Xu YP, Yang RH, Wang L, Chen F, Luo S, Yang M, Yan Y. Pan D, et al. Amino Acids. 2014 Jun;46(6):1481-9. doi: 10.1007/s00726-014-1718-y. Epub 2014 Mar 17. Amino Acids. 2014. PMID: 24633452

6

Toward the Optimization of Bombesin-Based Radiotracers for Tumor Targeting.

Valverde IE, Vomstein S, Mindt TL. Valverde IE, et al. J Med Chem. 2016 Apr 28;59(8):3867-77. doi: 10.1021/acs.jmedchem.6b00025. Epub 2016 Apr 15. J Med Chem. 2016. PMID: 27054526

7

Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.

Lim JC, Cho EH, Kim JJ, Choi SM, Lee SY, Nam SS, Park UJ, Park SH. Lim JC, et al. Nucl Med Biol. 2015 Mar;42(3):234-41. doi: 10.1016/j.nucmedbio.2014.10.008. Epub 2014 Oct 22. Nucl Med Biol. 2015. PMID: 25498002

8

Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.

Nock BA, Kaloudi A, Lymperis E, Giarika A, Kulkarni HR, Klette I, Singh A, Krenning EP, de Jong M, Maina T, Baum RP. Nock BA, et al. J Nucl Med. 2017 Jan;58(1):75-80. doi: 10.2967/jnumed.116.178889. Epub 2016 Aug 4. J Nucl Med. 2017. PMID: 27493272 Free article.

9

Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature.

Reubi JC, Fleischmann A, Waser B, Rehmann R. Reubi JC, et al. Peptides. 2011 Jul;32(7):1457-62. doi: 10.1016/j.peptides.2011.05.007. Epub 2011 May 13. Peptides. 2011. PMID: 21605611

10

Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.

Elshafae SM, Hassan BB, Supsavhad W, Dirksen WP, Camiener RY, Ding H, Tweedle MF, Rosol TJ. Elshafae SM, et al. Prostate. 2016 Jun;76(9):796-809. doi: 10.1002/pros.23154. Epub 2016 Mar 4. Prostate. 2016. PMID: 26939805 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year